SAN DIEGO--July 6, 2006--Accelrys, (NASDAQ:ACCL), the leader in data pipelining and workflow tools, announced the license of its enterprise technology, Pipeline Pilot(TM), to Jazz Pharmaceuticals, Inc. Pipeline Pilot, from the SciTegic division of Accelrys, has provided Jazz Pharmaceuticals with a flexible and scalable platform to develop a full-featured sales force automation tool and a robust sales reporting architecture. The web-based contact management system gives their sales force real-time access to data and customized reports. Jazz Pharmaceuticals will also use the platform to integrate applications that process clinical and other life sciences data.

"With the help of the SciTegic consulting team, we were able to build our custom customer relationship management (CRM) solution at a fraction of the time and cost of other solutions on the market without compromising the quality and functionality," said Jerry Yu, Senior Manager, Information Technology at Jazz Pharmaceuticals. "We are also looking forward to leveraging the power and potential that Pipeline Pilot provides in future projects here at Jazz Pharmaceuticals."

With the use of this powerful solution in combination with mobile devices, Jazz Pharmaceuticals specialty sales consultants can get on-demand access to sales and contact information at their fingertips. "Obtaining reports from disparate databases has never been easier than with the tools we are able to build using Pipeline Pilot," said Eric Mosbrooker, Director, Commercial Analytics at Jazz Pharmaceuticals.

"We are excited to be working with Jazz Pharmaceuticals, as their use of Pipeline Pilot highlights its broad applicability as a workflow platform," said Mathew Hahn, Accelrys Chief Science and Technology Officer. "We believe that their choice of Pipeline Pilot validates the advantages of our platform, which can be applied to both scientific and non-scientific applications."

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is focused on helping patients by meeting unmet medical needs in neurology and psychiatry with important and innovative therapeutic products. Jazz Pharmaceuticals is aggressively building its product portfolio through a combination of commercialization and development activities. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals. For further information, please visit www.JazzPharmaceuticals.com.

About Accelrys, Inc.

Accelrys, Inc. (NASDAQ:ACCL) is a leading provider of software for computation, simulation, and the management and mining of scientific data used by biologists, chemists and materials scientists, including nanotechnology researchers, for product design as well as drug discovery and development. SciTegic, Inc., a division of Accelrys, has pioneered a new technology platform called "data pipelining" to process research discovery data with unprecedented flexibility. Accelrys technology and services are designed to meet the needs of today's leading research organizations. The company is headquartered in San Diego, California. Its materials research and development team is based at its European Headquarters and Centre of Excellence in Cambridge, UK. For more information about Accelrys, visit its website at http://www.accelrys.com/.